60 Degrees Pharma Announces 1:4 Reverse Stock Split to Comply with Nasdaq Listing Requirements.
ByAinvest
Thursday, Jan 15, 2026 8:07 am ET1min read
SXTP--
60 Degree Pharmaceuticals is set to undergo a 1:4 reverse stock split, effective January 20, 2026, to comply with Nasdaq's minimum bid price requirement. The company's common stock will begin trading on a post-reverse split basis under the symbol "SXTP". The new CUSIP number will be 83006G500. The reverse split aims to maintain the company's listing on the Nasdaq.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet